InsidersTradesSigma
Total declarations
Companies
▲ Purchases (4 ops.)
▼ Sales (0 ops.)
Discover the full record of transactions filed by Quinn Anthony G., Chief Executive Officer. Insider active across 2 companies, notably Generation Bio Co.. Aggregated, 6 disclosures have been published. Split: 4 buys · 0 sell. Total volume traded: €517k. History available since 28 October 2021. The latest transaction was disclosed on 16 March 2022 (Acquisition). Regulator: SEC (Form 4). The full history is free.
Declarations6 total
80,079 shares@ US$2.34433.1% of flowCommon StockSEC:0001209191-22-019929:0
Ideal exit: 11 Dec 2022 (T+270)
34,777 shares@ US$2.06412.6% of flowCommon StockSEC:0001209191-22-018942:0
Ideal exit: 6 Dec 2022 (T+270)
43,108 shares@ US$3.7027.2% of flowCommon StockSEC:0001209191-21-069350:0
Ideal exit: 5 Sept 2022 (T+270)
43,108 shares@ US$3.70100.0% of flowCommon StockSEC:0001209191-21-069350
Ideal exit: 5 Sept 2022 (T+270)
72,837 shares0Common StockSEC:0001415889-21-005028
72,837 shares0Common StockSEC:0001415889-21-005028:0
6 of 6 declarations
About Quinn Anthony G.
Anthony G. Quinn is the President and CEO of Generation Bio Co. and Aeglea BioTherapeutics, Inc. He leads the operations and overall strategy of the companies, focusing on innovation in the biopharmaceutical sector.
